Identification and Validation of an Antivirulence Agent Targeting HlyU-Regulated Virulence in Vibrio vulnificus

Antimicrobial resistance (AMR) in pathogens is the result of indiscriminate use of antibiotics and consequent metabolic/genetic modulation to evolve survival strategies and clonal-selection in AMR strains. As an alternative to antibiotic treatment, antivirulence strategies are being developed, not o...

Full description

Bibliographic Details
Main Authors: Saba Imdad, Akhilesh Kumar Chaurasia, Kyeong Kyu Kim
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fcimb.2018.00152/full
_version_ 1819127183772221440
author Saba Imdad
Akhilesh Kumar Chaurasia
Kyeong Kyu Kim
author_facet Saba Imdad
Akhilesh Kumar Chaurasia
Kyeong Kyu Kim
author_sort Saba Imdad
collection DOAJ
description Antimicrobial resistance (AMR) in pathogens is the result of indiscriminate use of antibiotics and consequent metabolic/genetic modulation to evolve survival strategies and clonal-selection in AMR strains. As an alternative to antibiotic treatment, antivirulence strategies are being developed, not only to combat bacterial pathogenesis, but also to avoid emerging antibiotic resistance. Vibrio vulnificus is a foodborne pathogen that causes gastroenteritis, necrotizing wound infections, and sepsis with a high rate of mortality. Here, we developed an inhibitor-screening reporter platform to target HlyU, a master transcriptional regulator of virulence factors in V. vulnificus by assessing rtxA1 transcription under its control. The inhibitor-screening platform includes wild type and ΔhlyU mutant strains of V. vulnificus harboring the reporter construct PrtxA1::luxCDABE for desired luminescence signal detection and control background luminescence, respectively. Using the inhibitor-screening platform, we identified a small molecule, fursultiamine hydrochloride (FTH), that inhibits the transcription of the highly invasive repeat-in-toxin (rtxA1) and hemolysin (vvhA) along with other HlyU regulated virulence genes. FTH has no cytotoxic effects on either host cells or pathogen at the tested concentrations. FTH rescues host cells from the necrotic cell-death induced by RtxA1 and decreases the hemolytic activity under in vitro conditions. The most important point is that FTH treatment does not induce the antivirulence resistance. Current study validated the antivirulence strategy targeting the HlyU virulence transcription factor and toxin-network of V. vulnificus and demonstrated that FTH, exhibits a potential to inhibit the pathogenesis of deadly, opportunistic human pathogen, V. vulnificus without inducing AMR.
first_indexed 2024-12-22T08:07:53Z
format Article
id doaj.art-22fe2c13a2284dad8cc2dd8b04896d21
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-12-22T08:07:53Z
publishDate 2018-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-22fe2c13a2284dad8cc2dd8b04896d212022-12-21T18:33:06ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882018-05-01810.3389/fcimb.2018.00152355897Identification and Validation of an Antivirulence Agent Targeting HlyU-Regulated Virulence in Vibrio vulnificusSaba ImdadAkhilesh Kumar ChaurasiaKyeong Kyu KimAntimicrobial resistance (AMR) in pathogens is the result of indiscriminate use of antibiotics and consequent metabolic/genetic modulation to evolve survival strategies and clonal-selection in AMR strains. As an alternative to antibiotic treatment, antivirulence strategies are being developed, not only to combat bacterial pathogenesis, but also to avoid emerging antibiotic resistance. Vibrio vulnificus is a foodborne pathogen that causes gastroenteritis, necrotizing wound infections, and sepsis with a high rate of mortality. Here, we developed an inhibitor-screening reporter platform to target HlyU, a master transcriptional regulator of virulence factors in V. vulnificus by assessing rtxA1 transcription under its control. The inhibitor-screening platform includes wild type and ΔhlyU mutant strains of V. vulnificus harboring the reporter construct PrtxA1::luxCDABE for desired luminescence signal detection and control background luminescence, respectively. Using the inhibitor-screening platform, we identified a small molecule, fursultiamine hydrochloride (FTH), that inhibits the transcription of the highly invasive repeat-in-toxin (rtxA1) and hemolysin (vvhA) along with other HlyU regulated virulence genes. FTH has no cytotoxic effects on either host cells or pathogen at the tested concentrations. FTH rescues host cells from the necrotic cell-death induced by RtxA1 and decreases the hemolytic activity under in vitro conditions. The most important point is that FTH treatment does not induce the antivirulence resistance. Current study validated the antivirulence strategy targeting the HlyU virulence transcription factor and toxin-network of V. vulnificus and demonstrated that FTH, exhibits a potential to inhibit the pathogenesis of deadly, opportunistic human pathogen, V. vulnificus without inducing AMR.http://journal.frontiersin.org/article/10.3389/fcimb.2018.00152/fullVibrio vulnificusrtxA1hemolysinhlyUdrug identification and repositioningfursultiamine hydrochloride
spellingShingle Saba Imdad
Akhilesh Kumar Chaurasia
Kyeong Kyu Kim
Identification and Validation of an Antivirulence Agent Targeting HlyU-Regulated Virulence in Vibrio vulnificus
Frontiers in Cellular and Infection Microbiology
Vibrio vulnificus
rtxA1
hemolysin
hlyU
drug identification and repositioning
fursultiamine hydrochloride
title Identification and Validation of an Antivirulence Agent Targeting HlyU-Regulated Virulence in Vibrio vulnificus
title_full Identification and Validation of an Antivirulence Agent Targeting HlyU-Regulated Virulence in Vibrio vulnificus
title_fullStr Identification and Validation of an Antivirulence Agent Targeting HlyU-Regulated Virulence in Vibrio vulnificus
title_full_unstemmed Identification and Validation of an Antivirulence Agent Targeting HlyU-Regulated Virulence in Vibrio vulnificus
title_short Identification and Validation of an Antivirulence Agent Targeting HlyU-Regulated Virulence in Vibrio vulnificus
title_sort identification and validation of an antivirulence agent targeting hlyu regulated virulence in vibrio vulnificus
topic Vibrio vulnificus
rtxA1
hemolysin
hlyU
drug identification and repositioning
fursultiamine hydrochloride
url http://journal.frontiersin.org/article/10.3389/fcimb.2018.00152/full
work_keys_str_mv AT sabaimdad identificationandvalidationofanantivirulenceagenttargetinghlyuregulatedvirulenceinvibriovulnificus
AT akhileshkumarchaurasia identificationandvalidationofanantivirulenceagenttargetinghlyuregulatedvirulenceinvibriovulnificus
AT kyeongkyukim identificationandvalidationofanantivirulenceagenttargetinghlyuregulatedvirulenceinvibriovulnificus